Isoray, Inc.

ASE:ISR  
0.88
+0.04 (+4.39%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)129.42M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2.43 Million
Adjusted EPS-$0.01
See more estimates
10-Day MA$0.89
50-Day MA$1.08
200-Day MA$0.89
See more pivots

Isoray, Inc. Stock, ASE:ISR

350 Hills Street, Suite 106, Richland, Washington 99354-5511
United States of America
Phone: +1.509.375.1202
Number of Employees: 53

Description

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The company focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.